National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 13563 [2015-05826]
Download as PDF
<![CDATA[
13563
Federal Register / Vol. 80, No. 50 / Monday, March 16, 2015 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
NICHD Grantee ...............................................................................................
NIDCD Grantee ...............................................................................................
NIMH Grantee ..................................................................................................
NINDS Grantee ................................................................................................
NCI Grantee .....................................................................................................
NIEHS Grantee ................................................................................................
200
200
200
200
400
200
Dated: March 5, 2015.
Joellen M. Austin,
Associate Director for Management, NIEHS,
NIH.
Dated: March 10, 2015.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–05927 Filed 3–13–15; 8:45 am]
[FR Doc. 2015–05826 Filed 3–13–15; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Submission for OMB Review; 30-Day
Comment Request: Outcome
Evaluation of the Broadening
Experiences in Scientific Training
(BEST) Program (OD)
Rmajette on DSK2VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID SBIR—Technology
Transfer Direct Phase II (SBIR–TT) (R44).
Date: April 7, 2015.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892,
(Telephone Conference Call).
Contact Person: Thomas F. Conway,
Scientific Review Officer, Scientific Review
Program, DEA/NIAID/NIH/DHHS, 5601
Fishers, Rockville, MD 20892, 240–669–5069,
thomas.conway@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
VerDate Sep<11>2014
14:09 Mar 13, 2015
Jkt 235001
Under the provisions of
section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the Office of
Strategic Coordination, an office of the
Division of Program Coordination,
Planning, and Strategic Initiatives,
within the Office of the Director at the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below. This proposed
information collection was previously
published in the Federal Register on
August 26, 2014, (79 FR 50921) and
allowed 60-days for public comment.
During the 60-day comment period, two
requests for information were received.
Both individuals requested the data
collection plans and the data collection
instruments and one also asked for
background information. In response to
these two requests, electronic copies of
the following surveys were emailed:
Entrance, Interim, Exit, and Post-Exit.
Additionally, both individuals were
provided with a brief overview of the
program and a link to the NIH Web site
that contains detailed information about
the BEST program and the awardees. No
additional comments were received
from the two individuals who requested
this information. The purpose of this
notice is to allow an additional 30 days
for public comment. The Office of
Strategic Coordination (OSC), an office
SUMMARY:
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
1
1
1
1
1
1
Average
time per
response
(in hours)
Total annual
burden hour
30/60
30/60
30/60
30/60
30/60
30/60
100
100
100
100
200
100
of the Division of Program Coordination,
Planning, and Strategic Initiatives
(DPCPSI), within the Office of the
Director (OD) at the National Institutes
of Health (NIH) may not conduct or
sponsor, and the respondent is not
required to respond to, an information
collection that has been extended,
revised, or implemented on or after
October 1, 1995, unless it displays a
currently valid OMB control number.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs,
OIRA_submission@omb.eop.gov or by
fax to 202–395–6974, Attention: NIH
Desk Officer.
Comment due date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30-days of the date of
this publication.
DATES:
To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact Dr. Patricia
Labosky, Office of Strategic
Coordination, Division of Program
Coordination, Planning, and Strategic
Initiatives, Office of the Director, NIH, 1
Center Drive, MSC 0189, Building 1,
Room 214A, Bethesda, MD 20892–0189.
Telephone: 301–594–4863. Fax: 301–
435–7268. or email your request,
including your address to:
Workforce_Award@mail.nih.gov. Formal
requests for additional plans and
instruments must be requested in
writing.
Proposed Collection: Outcome
Evaluation of the Broadening
Experiences in Scientific Training
(BEST) Program (OD), 0925–NEW, the
Office of Strategic Coordination (OSC),
an office of the Division of Program
Coordination, Planning, and Strategic
Initiatives (DPCPSI), within the Office of
FOR FURTHER INFORMATION CONTACT:
E:\FR\FM\16MRN1.SGM
16MRN1
]]>Agencies
[Federal Register Volume 80, Number 50 (Monday, March 16, 2015)]
[Notices]
[Page 13563]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-05826]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; NIAID SBIR--Technology Transfer
Direct Phase II (SBIR-TT) (R44).
Date: April 7, 2015.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 5601 Fishers Lane,
Rockville, MD 20892, (Telephone Conference Call).
Contact Person: Thomas F. Conway, Scientific Review Officer,
Scientific Review Program, DEA/NIAID/NIH/DHHS, 5601 Fishers,
Rockville, MD 20892, 240-669-5069, thomas.conway@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: March 10, 2015.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-05826 Filed 3-13-15; 8:45 am]
BILLING CODE 4140-01-P
